Literature DB >> 1595834

Extended resection for locally advanced colorectal carcinoma.

S A Curley1, G W Carlson, C R Shumate, K I Wishnow, F C Ames.   

Abstract

We reviewed the medical records of 101 patients who underwent extended resection for locally advanced colorectal carcinoma between 1965 and 1989. Preoperative symptoms related to the genitourinary system were present in 46 patients. Malignant invasion of genitourinary structures by colorectal carcinoma was found in 43 of these 46 patients (93%). In contrast, 51% of the patients without such symptoms had malignant invasion of contiguous structures. Preoperative intravenous pyelography, computerized tomographic scans, and cystoscopy correctly predicted the presence or absence of malignant invasion in 89%, 83%, and 87% of patients, respectively. Tumor-positive resection margins had a negative impact on survival (mean survival: 11.4 months). The 5-year actuarial survival rate for the patients who underwent a curative extended resection (margins tumor negative) was 54%. A thorough preoperative evaluation can identify a significant number of patients with colorectal cancer extending into adjacent organs and structures. Such evaluation is vital for operative planning and patient preparation, since an appropriate extended resection can produce long-term local control and patient survival.

Entities:  

Mesh:

Year:  1992        PMID: 1595834     DOI: 10.1016/0002-9610(92)90554-5

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  23 in total

1.  Thirty-day outcomes in patients treated with en bloc colectomy and pancreatectomy for locally advanced carcinoma of the colon.

Authors:  Ian M Paquette; Brian R Swenson; Mary R Kwaan; Anders F Mellgren; Robert D Madoff
Journal:  J Gastrointest Surg       Date:  2011-09-29       Impact factor: 3.452

2.  Multivisceral resection for locally advanced primary colon and rectal cancer: an analysis of prognostic factors in 201 patients.

Authors:  Thomas Lehnert; Mascha Methner; Andreas Pollok; Anja Schaible; Ulf Hinz; Christian Herfarth
Journal:  Ann Surg       Date:  2002-02       Impact factor: 12.969

3.  [Multivisceral resection of advanced colorectal cancer].

Authors:  K H Schultheis; S Ruckriegel; C Gebhardt
Journal:  Langenbecks Arch Chir       Date:  1994

4.  Effectiveness of multivisceral resection in surgery for gastrointestinal cancers.

Authors:  A Balogh; J Karádi
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

5.  SAGES evidence-based guidelines for the laparoscopic resection of curable colon and rectal cancer.

Authors:  Marc Zerey; Lisa Martin Hawver; Ziad Awad; Dimitrios Stefanidis; William Richardson; Robert D Fanelli
Journal:  Surg Endosc       Date:  2012-12-13       Impact factor: 4.584

6.  Clinicopathologic variables affecting survival of distal colorectal cancer patients with macroscopic invasion into the adjacent organs.

Authors:  T Nakamura; H Yoshioka; M Ohno; T Kuniyasu; Y Tabuchi
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

7.  Surgical management of locally advanced and locally recurrent colon cancer.

Authors:  Ron G Landmann; Martin R Weiser
Journal:  Clin Colon Rectal Surg       Date:  2005-08

Review 8.  Biology of human colon cancer metastasis.

Authors:  M Gutman; I J Fidler
Journal:  World J Surg       Date:  1995 Mar-Apr       Impact factor: 3.352

9.  Management of patients with carcinoma of the right colon invading the duodenum or pancreatic head.

Authors:  David Fuks; Patrick Pessaux; Jean-Jacques Tuech; François Mauvais; Olivier Bréhant; Frédéric Dumont; Denis Chatelain; Thierry Yzet; Jean-Paul Joly; Benoit Lefebure; Sushil Deshpande; Jean-Pierre Arnaud; Pierre Verhaeghe; Jean-Marc Regimbeau
Journal:  Int J Colorectal Dis       Date:  2008-01-24       Impact factor: 2.571

10.  En bloc resection for right colon cancer directly invading duodenum or pancreatic head.

Authors:  Won-Suk Lee; Woo Yong Lee; Ho-Kyung Chun; Seong-Ho Choi
Journal:  Yonsei Med J       Date:  2009-12-18       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.